Development of a quantitative RT-PCR for the human APO-1 (FAS/CD95) ligand and monitoring of ligand expression in normal and malignant T cells

被引：0
|
作者：
Herr, I
Balemans, L
Friesen, C
Debatin, KM
机构：
[1] UNIV HEIDELBERG,CHILDRENS HOSP,W-6900 HEIDELBERG,GERMANY
[2] GERMAN CANC RES CTR,DIV MOLEC ONCOL,W-6900 HEIDELBERG,GERMANY
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：639 / 639
页数：1
相关论文
共 50 条
  • [41] Regulation of apoptosis through CD95 (APO-1/FAS) receptor/ligand interaction
    Debatin, KM
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 40 - 40
  • [42] Regulation of apoptosis through CD95 (APO-1/FAS) receptor/ligand interaction
    Debatin, KM
    IMMUNOLOGY, 1996, 89 : SR68 - SR68
  • [43] Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape
    Hahne, M
    Rimoldi, D
    Schroter, M
    Romero, P
    Schreier, M
    French, LE
    Schneider, P
    Bornand, T
    Fontana, A
    Lienard, D
    Cerottini, JC
    Tschopp, J
    SCIENCE, 1996, 274 (5291) : 1363 - 1366
  • [44] Interferon α augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression
    Kaser, A
    Nagata, S
    Tilg, H
    CYTOKINE, 1999, 11 (10) : 736 - 743
  • [45] Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation
    Müschen, M
    Warskulat, U
    Peters-Regehr, T
    Bode, JG
    Kubitz, R
    Häussinger, D
    GASTROENTEROLOGY, 1999, 116 (03) : 666 - 677
  • [46] Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines
    Rajashekhar, G
    Loganath, A
    Roy, AC
    Mongelli, JM
    GYNECOLOGIC ONCOLOGY, 2003, 91 (01) : 101 - 111
  • [47] Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system
    Jaber, BL
    Perianayagam, MC
    Balakrishnan, VS
    King, AJ
    Pereira, BJG
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, 69 (06) : 1006 - 1012
  • [48] Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer
    Gratas, C
    Tohma, Y
    Barnas, C
    Taniere, P
    Hainaut, P
    Ohgaki, H
    CANCER RESEARCH, 1998, 58 (10) : 2057 - 2062
  • [49] Fas/APO-1 (CD95) expression in myelodysplastic syndromes
    Lepelley, P
    Grardel, N
    Erny, O
    Iaru, T
    Obein, V
    Cosson, A
    Fenaux, P
    LEUKEMIA & LYMPHOMA, 1998, 30 (3-4) : 307 - 312
  • [50] CD95 (APO-1/Fas) and the Fas ligand in activation induced cell death (AICD) of B cells.
    Daniel, PT
    Oettinger, U
    Mapara, MY
    Bommert, K
    Bargou, RC
    Dorken, B
    BLOOD, 1995, 86 (10) : 1259 - 1259
12345